Congress Proposes New Rules to Help Patients Skip Insurance "Step Therapy" for Medications
Safe Step Act
Stalled
No legislative action in over 90 days.
↔Companion bill: Congress Proposes New Rules to Help Patients Skip Insurance 'Fail-First' Drug RequirementsLegislative Progress
Key Points
Impact Analysis
Personal Impact
Milestones
Related News
5 articlesCongress reintroduces Safe Step Act to amend step therapy policies
In September 2025, members of the U.S. House and Senate reintroduced the Safe Step Act, requiring group health insurance plans to offer a timely exceptions process for 'fail-first' protocols. The bill aims to protect patients from delays in treatment that can worsen chronic conditions.
Safe Step Act Supports Timely Access to Essential Therapy
The Safe Step Act, a bipartisan federal bill establishing guardrails for step therapy, represents a potential turning point for clinicians and patients. By codifying timely exception processes and promoting transparency, the legislation aims to align insurer protocols with clinical judgment.
Oncologist warns PBM step therapy has 'crossed a dangerous line'
An oncologist highlights how step therapy enforced by PBMs prevents timely access to essential medicines. The article discusses the reintroduction of the Safe Step Act on Sept. 19, 2025, as a critical measure to allow exceptions when alternative treatments could cause harm or delay care.
Related Bills
1 billSource Information
Analysis generated by AI. Always verify with official sources.